PVI
CLSD

Pura Vida Investments’s Clearside Biomedical CLSD Stock Holding History

Pura Vida Investments’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,375
Closed -$311K – 84
2018
Q3 		$311K Buy
+3,375
New +$401K 0.07% 105
2018
Q2 		– Sell
-4,507
Closed -$725K – 100
2018
Q1 		$725K Buy
+4,507
New +$549K 0.43% 53

Other funds holding CLSD

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pura Vida Investments's CLSD Position: Q4 2018 in Review

Pura Vida Investments sold out of Clearside Biomedical (CLSD) in Q4 2018, closing a stake of 3,375 shares — an estimated $311K sold.

Pura Vida Investments first reported a position in CLSD in Q1 2018 and held it in 2 quarters. The position peaked at $725K in Q1 2018. 69 funds tracked by Wall St. Rank hold CLSD as of Q4 2018.

  • Pura Vida Investments reported no remaining Clearside Biomedical position as of Q4 2018 after selling out during the quarter.
  • Pura Vida Investments sold 3,375 Clearside Biomedical shares in Q4 2018, an estimated $311K.
  • Pura Vida Investments first reported a position in Clearside Biomedical in Q1 2018 and held it in 2 quarters.
  • Pura Vida Investments's Clearside Biomedical position peaked at $725K in Q1 2018.
  • 69 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2018.

Based on Pura Vida Investments's 13F filing for Q4 2018, filed 14 Feb 2019.